SCHEMBL20171376

SCHEMBL20171376

Cc1ccc(CCc2nc(C3CC3)cs2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 5/20 0.51
NPC1 O15118 4/20 0.51
SMN1; SMN2 Q16637 3/20 0.51
ALDH1A1 P00352 3/20 0.51
MAPT P10636 2/20 0.51
TP53 P04637 1/20 0.51
NFKB1 P19838 1/20 0.51
FPR1 P21462 1/20 0.51
NFKB2 Q00653 1/20 0.51
RELA Q04206 1/20 0.51
HSD17B10 Q99714 1/20 0.51
LTA4H P09960 1/20 0.37
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
HPGD P15428 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
TMIGD3 P0DMS9 1/20 0.35
ADORA1 P30542 1/20 0.35
CYP1A2 P05177 1/20 0.34
CYP2A6 P11509 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22904608 0.73 MAPT (0.42) RAB9ANPC1SMN1; SMN2ALDH1A1MAPT
SCHEMBL22522130 0.73 AOC3 (0.52) RAB9ANPC1SMN1; SMN2ALDH1A1MAPT
SCHEMBL24963463 0.70 MAPT (0.39) RAB9ANPC1SMN1; SMN2ALDH1A1MAPT
SCHEMBL24258782 0.69 TMIGD3 (0.36) RAB9ANPC1SMN1; SMN2ALDH1A1MAPT
SCHEMBL5708660 0.67 DRD2 (0.40) ALDH1A1MAPTNFKB1HDAC1HDAC6
SCHEMBL8003695 0.67
SCHEMBL19288042 0.67 NOS1 (0.42) RAB9ANPC1SMN1; SMN2ALDH1A1HDAC1
SCHEMBL24259060 0.67 TMIGD3 (0.35) RAB9ANPC1SMN1; SMN2ALDH1A1MAPT
SCHEMBL5670311 0.66 NPC1 (0.36) RAB9ANPC1SMN1; SMN2ALDH1A1MAPT
SCHEMBL143961 0.65 CYP1A2 (0.68) ALDH1A1MEN1KMT2AL3MBTL1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3323815-A1 HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE Aerpio Therapeutics, Inc. (US) 2018-05-23 EP disclosed